Structures by: Foro S.
Total: 536
1-(3,5-dinitrobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H18N4O6
IUCrData (2020) 5, 11 x201523
a=25.348(2)Å b=7.3059(5)Å c=19.3470(10)Å
α=90° β=94.190(6)° γ=90°
Dihydroxy phenyl tetradecyl ketone
C20H32O3
IUCrData (2016) 1, 4 x160577
a=4.2047(6)Å b=34.146(4)Å c=13.347(3)Å
α=90.00° β=97.670(10)° γ=90.00°
Limonin
C26H30O8
IUCrData (2016) 1, 2 x160172
a=8.8770(10)Å b=14.533(2)Å c=17.748(2)Å
α=90.00° β=90.00° γ=90.00°
4-bromophenyl dipyrromethane
C15H13BrN2
IUCrData (2016) 1, 6 x161005
a=5.8132(8)Å b=19.763(2)Å c=11.6560(10)Å
α=90.00° β=96.850(10)° γ=90.00°
C24H21N3O3
C24H21N3O3
New Journal of Chemistry (2020) 44, 27 11471-11489
a=8.6833(4)Å b=13.4612(8)Å c=17.1272(9)Å
α=90° β=91.706(4)° γ=90°
C48H42N6O6Ru,2(F6P)
C48H42N6O6Ru,2(F6P)
New Journal of Chemistry (2020) 44, 27 11471-11489
a=8.8332(5)Å b=17.4183(9)Å c=17.9294(9)Å
α=63.300(4)° β=87.460(5)° γ=89.376(6)°
C48H42N6O6Ru,2(F6P),2(H2O)
C48H42N6O6Ru,2(F6P),2(H2O)
New Journal of Chemistry (2020) 44, 27 11471-11489
a=11.4094(5)Å b=12.1354(6)Å c=19.0576(8)Å
α=105.131(4)° β=95.341(4)° γ=101.205(4)°
C24H21N3O3
C24H21N3O3
New Journal of Chemistry (2020) 44, 27 11471-11489
a=7.5412(5)Å b=33.740(3)Å c=7.9862(5)Å
α=90° β=92.588(7)° γ=90°
C4H16N10O10Y,NO3
C4H16N10O10Y,NO3
RSC Advances (2019) 9, 54 31386
a=7.5428(7)Å b=11.256(1)Å c=11.976(1)Å
α=112.238(8)° β=96.414(7)° γ=94.215(7)°
C30H22O5V
C30H22O5V
RSC Adv. (2015)
a=12.7159(9)Å b=15.199(1)Å c=12.9016(9)Å
α=90.00° β=96.743(4)° γ=90.00°
C81H64AgClN2O2
C81H64AgClN2O2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 27 11015-11024
a=11.8068(6)Å b=14.7394(7)Å c=22.520(1)Å
α=90.00° β=101.746(5)° γ=90.00°
(<i>E</i>)-<i>N</i>-{2-[2-(Benzylidene)hydrazinyl]-2-oxoethyl}-4-methylbenzenesulfonamide
C16H17N3O3S
Acta Crystallographica Section C (2018) 74, 11 1553-1560
a=20.764(2)Å b=6.6904(6)Å c=24.174(3)Å
α=90.00° β=97.100(10)° γ=90.00°
(<i>E</i>)-<i>N</i>-{2-[2-(4-Bromobenzylidene)hydrazinyl]-2-oxoethyl}-4-methylbenzenesulfonamide
C16H16BrN3O3S
Acta Crystallographica Section C (2018) 74, 11 1553-1560
a=6.7308(7)Å b=10.3220(10)Å c=13.723(2)Å
α=75.562(8)° β=85.556(9)° γ=75.046(8)°
(<i>E</i>)-<i>N</i>-{2-[2-(4-Chlorobenzylidene)hydrazinyl]-2-oxoethyl}-4-methylbenzenesulfonamide
C16H16ClN3O3S
Acta Crystallographica Section C (2018) 74, 11 1553-1560
a=6.7101(6)Å b=10.3590(10)Å c=13.5000(10)Å
α=76.049(8)° β=85.846(9)° γ=74.823(8)°
(<i>E</i>)-<i>N</i>-(2-{2-[4-(Dimethylamino)benzylidene]hydrazinyl}-2-oxoethyl)-4-methylbenzene-sulfonamide
C18H22N4O3S
Acta Crystallographica Section C (2018) 74, 11 1553-1560
a=6.9310(10)Å b=11.076(2)Å c=12.935(3)Å
α=87.37(2)° β=81.44(2)° γ=74.42(2)°
(<i>E</i>)-<i>N</i>-{2-[2-(4-Methoxybenzylidene)hydrazinyl]-2-oxoethyl}-4-methylbenzenesulfonamide
C17H19N3O4S
Acta Crystallographica Section C (2018) 74, 11 1553-1560
a=6.8887(8)Å b=10.7780(10)Å c=12.411(2)Å
α=95.260(10)° β=93.430(10)° γ=104.820(10)°
3-Amino-1<i>H</i>-pyrazol-2-ium 3,5-dinitrobenzoate monohydrate
C7H3N2O6,C3H6N3,H2O
Acta Crystallographica Section E (2021) 77, 1 34-41
a=6.6864(7)Å b=8.1857(9)Å c=12.6490(10)Å
α=79.424(9)° β=85.583(9)° γ=75.586(9)°
Bis(3-amino-1<i>H</i>-pyrazol-2-ium) fumarate—–fumaric acid (1/1) 2C~3~H~6~N~3~^+^\χdotC~4~H~2~O~4~^2-^\χdotC~4~H~4~O~4~, (II). The reaction of 3-amino-1<i>H</i>-pyrazole with a dilute solution of nitric acid in methanol yields an second, orthorhombic polymorph of 3-amino-1<i>H</i>-pyrazol-2-ium nitrate, C~3~H~6~N~3~^+^\χdotNO~3~^-^
2(C3H6N3),C4H2O42,C4H4O4
Acta Crystallographica Section E (2021) 77, 1 34-41
a=8.5410(4)Å b=14.0507(7)Å c=7.5137(4)Å
α=90° β=98.827(6)° γ=90°
3-Amino-1<i>H</i>-pyrazol-2-ium nitrate
C3H6N3,NO3
Acta Crystallographica Section E (2021) 77, 1 34-41
a=7.2700(10)Å b=9.907(2)Å c=8.551(2)Å
α=90° β=90° γ=90°
1-(4-Fluorobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19FN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=7.3286(6)Å b=11.3388(7)Å c=20.3040(10)Å
α=90° β=90° γ=90°
1-(4-Iodobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19IN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=10.9626(5)Å b=11.3258(6)Å c=14.8234(7)Å
α=90° β=104.520(5)° γ=90°
1-(4-Chlorobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19ClN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=29.7690(10)Å b=11.3173(4)Å c=20.4028(8)Å
α=90° β=90° γ=90°
1-(2-Fluorobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19FN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=7.4510(10)Å b=11.199(3)Å c=19.138(5)Å
α=90° β=99.59(2)° γ=90°
1-(4-Bromobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19BrN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=15.0779(7)Å b=11.2868(6)Å c=20.5297(9)Å
α=90° β=90° γ=90°
1-(3-Iodobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19IN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=7.4528(4)Å b=17.1306(9)Å c=27.9030(10)Å
α=90° β=90° γ=90°
Diethyl (<i>RS</i>)-2-[(4-chlorophenyl)(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)methyl]propanedioate
C24H25ClN2O5
Acta Crystallographica Section E (2020) 76, 10 1605-1610
a=13.5609(8)Å b=20.2800(10)Å c=17.7280(10)Å
α=90° β=95.363(5)° γ=90°
Diethyl (<i>RS</i>)-2-[(4-bromophenyl)(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)methyl]propanedioate
C24H25BrN2O5
Acta Crystallographica Section E (2020) 76, 10 1605-1610
a=13.5644(5)Å b=20.3405(7)Å c=17.4818(8)Å
α=90° β=94.858(4)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 4-chlorobenzoate
C11H17N2O,C7H4ClO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.4010(10)Å b=7.8880(10)Å c=15.410(3)Å
α=100.28(2)° β=94.400(10)° γ=94.140(10)°
4-(2-Methoxyphenyl)piperazin-1-ium 4-bromobenzoate
C11H17N2O,C7H4BrO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.4313(5)Å b=7.9163(5)Å c=15.5212(9)Å
α=101.565(5)° β=94.780(5)° γ=92.691(5)°
4-(2-Methoxyphenyl)piperazin-1-ium 4-iodobenzoate
C11H17N2O,C7H4IO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.1129(4)Å b=11.2722(7)Å c=12.5923(8)Å
α=69.852(5)° β=74.681(5)° γ=79.121(5)°
4-(2-Methoxyphenyl)piperazin-1-ium 2-fluorobenzoate
C11H17N2O,C7H4FO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=19.9400(10)Å b=10.2705(7)Å c=9.0148(7)Å
α=90° β=109.663(8)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 2-chlorobenzoate
C11H17N2O,C7H4ClO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.9974(8)Å b=27.611(2)Å c=8.5972(9)Å
α=90° β=106.400(10)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 2-bromobenzoate
C11H17N2O,C7H4BrO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=6.9824(2)Å b=13.2292(4)Å c=19.4903(7)Å
α=90° β=90° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 2-iodobenzoate
C11H17N2O,C7H4IO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.0101(4)Å b=13.3796(6)Å c=19.5524(6)Å
α=90° β=90° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 2-methylbenzoate
C11H17N2O,C8H7O2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.8260(10)Å b=10.320(2)Å c=12.055(3)Å
α=78.37(2)° β=78.27(2)° γ=73.83(2)°
4-(2-Methoxyphenyl)piperazin-1-ium 4-aminobenzoate
C11H17N2O,C7H6NO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=14.9220(10)Å b=7.6951(5)Å c=15.5600(10)Å
α=90° β=106.911(8)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 4-nitrobenzoate
C11H17N2O,C7H4NO4
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.5174(5)Å b=7.9761(5)Å c=29.860(2)Å
α=90° β=97.322(6)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 3,5-dinitrobenzoate dihydrate
C11H17N2O,C7H3N2O6,2(H2O)
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.8448(6)Å b=11.4635(9)Å c=12.0747(9)Å
α=94.406(7)° β=105.075(8)° γ=93.717(7)°
4-(2-Methoxyphenyl)piperazin-1-ium 2,4,6-trinitrophenolate
C11H17N2O,C6H2N3O7
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=9.4151(5)Å b=9.8721(5)Å c=10.9572(5)Å
α=77.524(4)° β=81.360(5)° γ=81.002(5)°
4-(2-Methoxyphenyl)piperazin-1-ium hydrogen fumarate
C11H17N2O,0.5(C4H3O4),C1.14H0.86O1.14,C0.86H0.64O0.86)
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.8546(4)Å b=8.9626(6)Å c=11.2056(8)Å
α=79.043(5)° β=87.715(5)° γ=85.840(5)°
4-(2-Methoxyphenyl)piperazin-1-ium hydrogen maleate
C11H17N2O,C4H3O4
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=11.1076(6)Å b=11.1164(6)Å c=13.7649(7)Å
α=80.353(5)° β=78.353(5)° γ=74.406(5)°
4-(2-Methoxyphenyl)piperazin-1-ium hydrogen (2<i>R</i>,3<i>R</i>)-tartrate 1.698-hydrate
C11H17N2O,C4H5O6,1.698(H2O)
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.4790(10)Å b=7.0650(10)Å c=17.788(3)Å
α=90° β=101.58(2)° γ=90°
Clozapinium hydrogen bis(3,5-dinitrobenzoate)
C18H20ClN4,C7H3N2O6,C7H4N2O6
Acta Crystallographica Section E (2020) 76, 10 1629-1633
a=7.4102(6)Å b=24.629(2)Å c=18.4460(10)Å
α=90° β=98.478(6)° γ=90°
4-(4-Fluorophenyl)piperazin-1-ium 2-bromobenzoate 0.353-hydrate
C10H14FN2,C7H4BrO2,0.353(H2O)
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=7.2584(8)Å b=9.3470(10)Å c=13.767(2)Å
α=101.140(10)° β=95.980(10)° γ=109.440(10)°
4-(4-Fluorophenyl)piperazin-1-ium 2-fluorobenzoate monohydrate
C10H14FN2,C7H4FO2,H2O
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=6.5873(5)Å b=7.6616(6)Å c=17.3399(9)Å
α=97.842(6)° β=90.378(6)° γ=95.540(6)°
4-(4-Fluorophenyl)piperazin-1-ium 2-iodobenzoate
C10H14FN2,C7H4IO2
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=9.8892(3)Å b=11.6831(7)Å c=16.4547(9)Å
α=106.776(5)° β=93.327(4)° γ=104.874(4)°
4-(4-Fluorophenyl)piperazin-1-ium 2,4,6-trinitrophenolate
C10H14FN2,C6H2N3O7
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=16.658(2)Å b=6.6734(6)Å c=17.553(3)Å
α=90° β=117.84(2)° γ=90°
4-(4-Fluorophenyl)piperazin-1-ium 3,5-dinitrobenzoate
C10H14FN2,C7H3N2O6
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=19.8710(10)Å b=7.3420(7)Å c=26.306(2)Å
α=90° β=94.540(8)° γ=90°
<i>N</i>-{[4-(3-phenyl-4-sydnonylideneamino)-5-sulfanylidene-1<i>H</i>-1,2,4-triazol-3-yl]methyl}benzamide ethanol monosolvate
C19H15N7O3S,C2H6O
Acta Crystallographica Section E (2020) 76, 7 1057-1061
a=8.6313(6)Å b=10.8378(9)Å c=13.3840(10)Å
α=66.645(8)° β=79.287(8)° γ=85.151(8)°
<i>N</i>-({4-[3-(4-Methylphenyl)-4-sydnonylideneamino]-5-sulfanylidene-1<i>H</i>-1,2,4-triazol-3-yl}methyl)benzamide ethanol monosolvate
C20H17N7O3S,C2H6O
Acta Crystallographica Section E (2020) 76, 7 1057-1061
a=8.5631(5)Å b=11.1242(8)Å c=13.5632(9)Å
α=70.244(6)° β=76.086(7)° γ=84.058(6)°
4-(4-Fluorophenyl)piperazin-1-ium 2-hydroxy-3,5-dinitrobenzoate
C10H14FN2,C7H3N2O7
Acta Crystallographica Section E (2020) 76, 6 841-847
a=10.6829(6)Å b=13.1701(6)Å c=13.5563(7)Å
α=90° β=108.970(5)° γ=90°
4-(4-Fluorophenyl)piperazin-1-ium hydrogen oxalate
C10H14FN2,C2HO4
Acta Crystallographica Section E (2020) 76, 6 841-847
a=17.0606(6)Å b=5.7820(2)Å c=12.5815(5)Å
α=90° β=102.761(4)° γ=90°
4-(4-Fluorophenyl)piperazin-1-ium hydrogen (2<i>R</i>,3<i>R</i>)-tartrate monohydrate
C10H14FN2,C4H5O6,H2O
Acta Crystallographica Section E (2020) 76, 6 841-847
a=7.0961(4)Å b=7.4967(4)Å c=30.757(2)Å
α=90° β=90° γ=90°
<i>N</i>-(4-Methoxyphenyl)piperazine
C11H16N2O
Acta Crystallographica Section E (2020) 76, 4 488-495
a=6.9683(7)Å b=7.9683(8)Å c=18.975(2)Å
α=90° β=90° γ=90°
4-(4-Methoxyphenyl)piperazin-1-ium 3,5-dinitrobenzoate
C11H17N2O,C7H3N2O6
Acta Crystallographica Section E (2020) 76, 4 488-495
a=7.4365(4)Å b=10.6276(6)Å c=13.2700(6)Å
α=92.238(4)° β=97.057(4)° γ=108.618(5)°
4-(4-Methoxyphenyl)piperazin-1-ium 2,4,6-trinitrophenolate
C11H17N2O,C6H2N3O7
Acta Crystallographica Section E (2020) 76, 4 488-495
a=8.7568(6)Å b=6.6292(5)Å c=34.024(2)Å
α=90° β=96.987(6)° γ=90°
4-(4-Methoxyphenyl)piperazin-1-ium 4-aminobenzoate monohydrate
C7H6NO2,C11H17N2O,H2O
Acta Crystallographica Section E (2020) 76, 4 488-495
a=6.2590(7)Å b=7.4549(9)Å c=19.269(2)Å
α=83.280(10)° β=84.7400(10)° γ=85.380(10)°
2-(4-Chlorobenzyl)-6-(4-fluorophenyl)-5-[(1<i>H</i>-indol-3-yl)methyl]imidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C26H18ClFN4S
Acta Crystallographica Section E (2020) 76, 1 18-24
a=15.3400(10)Å b=11.1619(7)Å c=15.3850(10)Å
α=90° β=119.480(10)° γ=90°
2-(4-Chlorobenzyl)-5-[(1<i>H</i>-indol-3-yl)methyl]-6-phenylimidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C26H19ClN4S
Acta Crystallographica Section E (2020) 76, 1 18-24
a=16.456(7)Å b=10.420(2)Å c=26.391(7)Å
α=90° β=90.031(12)° γ=90°
6-(4-Bromophenyl)-2-(4-chlorobenzyl)-5-[(1<i>H</i>-indol-3-yl)methyl]imidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C26H18BrClN4S
Acta Crystallographica Section E (2020) 76, 1 18-24
a=9.5735(8)Å b=9.6860(9)Å c=25.644(2)Å
α=90° β=90° γ=90°
4-(4-Methoxyphenyl)piperazin-1-ium 4-bromobenzoate monohydrate
C11H17N2O,C7H4BrO2,H2O
Acta Crystallographica Section E (2019) 75, 10 1494-1506
a=6.2004(8)Å b=7.4957(9)Å c=20.440(2)Å
α=85.080(10)° β=87.370(10)° γ=85.000(10)°
4-(4-Methoxyphenyl)piperazin-1-ium 2-hydroxybenzoate
C11H17N2O,C7H5O3
Acta Crystallographica Section E (2019) 75, 10 1494-1506
a=6.5009(8)Å b=7.9735(9)Å c=32.155(4)Å
α=90° β=90° γ=90°
4-(4-Methoxyphenyl)piperazin-1-ium 2-hydroxy-3,5-dinitrobenzoate
C7H3N2O7,C11H17N2O
Acta Crystallographica Section E (2019) 75, 10 1494-1506
a=7.5500(9)Å b=7.6489(9)Å c=32.719(6)Å
α=90° β=91.300(10)° γ=90°
4-(4-Methoxyphenyl)piperazin-1-ium hydrogensuccinate
C11H17N2O,C4H5O4
Acta Crystallographica Section E (2019) 75, 10 1494-1506
a=9.3225(9)Å b=28.261(3)Å c=5.8228(8)Å
α=90° β=90° γ=90°
4-(4-Methoxyphenyl)piperazin-1-ium pyridine-3-carboxylate
C11H17N2O,C6H4NO2
Acta Crystallographica Section E (2019) 75, 10 1494-1506
a=9.2817(7)Å b=11.2905(7)Å c=30.309(2)Å
α=90° β=90° γ=90°
4-(4-Methoxyphenyl)piperazin-1-ium hydrogenfumarate
C11H17N2O,C4H3O4
Acta Crystallographica Section E (2019) 75, 10 1494-1506
a=9.0690(10)Å b=28.528(3)Å c=5.8375(9)Å
α=90° β=90° γ=90°
4-(4-Methoxyphenyl)piperazin-1-ium hydrogenmaleate
C11H17N2O,C4H3O4
Acta Crystallographica Section E (2019) 75, 10 1494-1506
a=9.0630(10)Å b=6.4956(9)Å c=26.093(3)Å
α=90° β=93.180(10)° γ=90°
4-(4-Methoxyphenyl)piperazin-1-ium trichloroacetate
C11H17N2O,C2Cl3O2
Acta Crystallographica Section E (2019) 75, 10 1494-1506
a=10.6117(11)Å b=13.8080(10)Å c=10.9137(8)Å
α=90° β=90° γ=90°
Bis(4-(4-methoxyphenyl)piperazin-1-ium) chloranilate(2-) dihydrate
C11H17N2O,0.5(C6Cl2O4),H2O
Acta Crystallographica Section E (2019) 75, 10 1494-1506
a=9.1597(5)Å b=15.1434(8)Å c=10.8742(6)Å
α=90° β=102.067(5)° γ=90°
(<i>E</i>)-<i>N</i>'-[4-(Piperidin-1-yl)benzylidene]benzenesulfonohydrazide
C18H21N3O2S
Acta Crystallographica Section E (2018) 74, 12 1826-1832
a=19.221(2)Å b=5.4270(7)Å c=17.143(2)Å
α=90° β=105.45(2)° γ=90°
(<i>E</i>)-4-Methyl-<i>N</i>'-[4-(piperidin-1-yl)benzylidene]benzenesulfonohydrazide
C19H23N3O2S
Acta Crystallographica Section E (2018) 74, 12 1826-1832
a=18.442(2)Å b=5.3250(4)Å c=19.412(2)Å
α=90° β=101.740(10)° γ=90°
(<i>E</i>)-4-Chloro-<i>N</i>'-[4-(piperidin-1-yl)benzylidene]benzenesulfonohydrazide
C18H20ClN3O2S
Acta Crystallographica Section E (2018) 74, 12 1826-1832
a=33.052(6)Å b=5.2580(10)Å c=43.026(8)Å
α=90° β=94.05(2)° γ=90°
(<i>E</i>)-4-Chloro-<i>N</i>'-(4-chlorobenzylidene)benzenesulfonohydrazide
C13H10Cl2N2O2S
Acta Crystallographica Section E (2018) 74, 12 1808-1814
a=5.9306(6)Å b=9.4770(10)Å c=13.040(2)Å
α=98.822(9)° β=96.046(9)° γ=92.416(9)°
(<i>E</i>)-4-chloro-<i>N</i>'-(4-Nitrobenzylidene)benzenesulfonohydrazide
C13H10ClN3O4S
Acta Crystallographica Section E (2018) 74, 12 1808-1814
a=19.9030(10)Å b=10.2517(7)Å c=15.0640(10)Å
α=90° β=103.929(7)° γ=90°
(<i>E</i>)-<i>N</i>'-(2-Chlorobenzylidene)-4-nitrobenzenesulfonohydrazide
C13H10ClN3O4S
Acta Crystallographica Section E (2018) 74, 12 1710-1716
a=4.9498(6)Å b=22.340(3)Å c=7.0003(9)Å
α=90° β=104.400(10)° γ=90°
(<i>E</i>)-<i>N</i>'-(2-Methylbenzylidene)-4-nitrobenzenesulfonohydrazide
C14H13N3O4S
Acta Crystallographica Section E (2018) 74, 12 1710-1716
a=7.1900(10)Å b=15.288(2)Å c=13.596(2)Å
α=90° β=97.68(2)° γ=90°
(<i>E</i>)-<i>N</i>'-(4-Methylbenzylidene)-4-nitrobenzenesulfonohydrazide monohydrate
C14H13N3O4S,H2O
Acta Crystallographica Section E (2018) 74, 12 1710-1716
a=22.589(2)Å b=5.4424(4)Å c=12.7180(9)Å
α=90° β=92.146(6)° γ=90°
(<i>E</i>)-<i>N</i>-{2-[2-(3-Chlorobenzylidene)hydrazinyl]-2-oxoethyl}-4-\ methylbenzenesulfonamide monohydrate
C16H16ClN3O3S,H2O
Acta Crystallographica Section E (2015) 71, 6 602-605
a=12.5760(10)Å b=12.769(2)Å c=12.4810(10)Å
α=90.00° β=115.580(10)° γ=90.00°
Aryl cyclohexyl nonanoid
C21H26O5
Acta Crystallographica Section E (2016) 72, 10 1408-1411
a=5.6630(8)Å b=8.7070(10)Å c=20.152(3)Å
α=81.690(10)° β=86.480(10)° γ=88.480(10)°
Bromo hydroxy seselin
C14H13BrO4
Acta Crystallographica Section E (2017) 73, 3 453-455
a=6.9573(6)Å b=23.465(2)Å c=8.3435(7)Å
α=90.00° β=100.790(10)° γ=90.00°
(<i>E</i>)-<i>N</i>'-Benzylidene-4-chlorobenzenesulfonohydrazide
C13H11ClN2O2S
Acta Crystallographica Section E (2018) 74, 11 1613-1618
a=14.949(2)Å b=10.0200(10)Å c=9.6410(10)Å
α=90° β=104.270(10)° γ=90°
(<i>E</i>)-4-Chloro-<i>N</i>'-(4-methylbenzylidene)benzenesulfonohydrazide
C14H13ClN2O2S
Acta Crystallographica Section E (2018) 74, 11 1613-1618
a=9.4060(10)Å b=5.8353(6)Å c=26.930(2)Å
α=90° β=99.621(9)° γ=90°
(<i>E</i>)-4-Chloro-<i>N</i>'-(2-methylbenzylidene)benzenesulfonohydrazide
C14H13ClN2O2S
Acta Crystallographica Section E (2018) 74, 11 1613-1618
a=15.034(2)Å b=10.1800(10)Å c=9.8119(9)Å
α=90° β=106.340(10)° γ=90°
(<i>Z</i>)-4-Chloro-<i>N</i>'-(4-oxothiazolidin-2-ylidene)benzenesulfonohydrazide monohydrate
C9H8ClN3O3S2,H2O
Acta Crystallographica Section E (2018) 74, 11 1569-1573
a=7.6276(6)Å b=11.0900(10)Å c=17.116(2)Å
α=96.950(10)° β=99.490(10)° γ=106.080(10)°
<i>N</i>,<i>N</i>'-bis(2-nitrophenyl)glutaramide
C17H16N4O6
Acta Crystallographica Section E (2018) 74, 10 1455-1459
a=9.6250(10)Å b=9.6730(10)Å c=18.500(2)Å
α=95.370(10)° β=93.380(10)° γ=92.770(10)°
4-(4-Methoxyphenyl)piperazin-1-ium 4-chlorobenzoate monohydrate
C11H17N2O,C7H4ClO2,H2O
Acta Crystallographica Section E (2019) 75, 10 1494-1506
a=6.2110(10)Å b=7.4810(10)Å c=20.144(4)Å
α=84.90(2)° β=87.48(2)° γ=85.19(2)°
4-(4-Methoxyphenyl)piperazin-1-ium benzoate monohydrate
C11H17N2O,C7H5O2,H2O
Acta Crystallographica Section E (2019) 75, 10 1494-1506
a=6.2150(10)Å b=7.5470(10)Å c=18.716(4)Å
α=84.34(2)° β=87.14(2)° γ=84.69(2)°
4-(4-Methoxyphenyl)piperazin-1-ium 4-fluorobenzoate monohydrate
C11H17N2O,C7H4FO2,H2O
Acta Crystallographica Section E (2019) 75, 10 1494-1506
a=6.2560(10)Å b=7.4890(10)Å c=19.097(2)Å
α=84.190(10)° β=86.98(2)° γ=84.62(2)°
1-Benzoyl-4-(4-methoxyphenyl)piperazine
C18H20N2O2
Acta Crystallographica Section E (2019) 75, 8 1253-1260
a=29.403(5)Å b=7.9811(14)Å c=6.7898(13)Å
α=90° β=97.352(12)° γ=90°
1-(2-Fluorobenzoyl)-4-(4-methoxyphenyl)piperazine
C18H19FN2O2
Acta Crystallographica Section E (2019) 75, 8 1253-1260
a=6.998(2)Å b=7.938(2)Å c=28.415(6)Å
α=90° β=92.20(3)° γ=90°
1-(2-Chlorobenzoyl)-4-(4-methoxyphenyl)piperazine
C18H19ClN2O2
Acta Crystallographica Section E (2019) 75, 8 1253-1260
a=13.0320(11)Å b=13.2470(13)Å c=19.258(2)Å
α=90° β=90° γ=90°
1-(2-Iodobenzoyl)-4-(4-methoxyphenyl)piperazine
C18H19IN2O2
Acta Crystallographica Section E (2019) 75, 8 1253-1260
a=12.7671(13)Å b=13.5429(12)Å c=20.2542(16)Å
α=90° β=90° γ=90°
1-(2-Hydroxybenzoyl)-4-(4-methoxyphenyl)piperazine
C18H20N2O3
Acta Crystallographica Section E (2019) 75, 8 1253-1260
a=9.7265(6)Å b=12.9084(9)Å c=24.8610(10)Å
α=90° β=90° γ=90°
1-(2-Bromoobenzoyl)-4-(4-methoxyphenyl)piperazine
C18H19BrN2O2
Acta Crystallographica Section E (2019) 75, 8 1253-1260
a=12.9119(14)Å b=13.3664(16)Å c=19.5019(19)Å
α=90° β=90° γ=90°
Bergapten
C12H8O4
Acta Crystallographica Section E (2016) 72, 8 1194-1196
a=3.8486(8)Å b=14.676(2)Å c=16.866(3)Å
α=90° β=92.12(2)° γ=90°
(<i>E</i>)-4-Chloro-<i>N</i>-{2-[2-(4-nitrobenzylidene)hydrazin-1-yl]-2-oxoethyl}benzenesulfonamide <i>N</i>,<i>N</i>-dimethylformamide monosolvate
C15H13ClN4O5S,C3H7NO
Acta Crystallographica Section E (2018) 74, 3 394-399
a=8.2400(10)Å b=10.6310(10)Å c=13.720(2)Å
α=108.150(10)° β=98.360(10)° γ=105.070(10)°
Dibromo Methoxy Seselin (DBMS)
C15H14Br2O4
Acta Crystallographica Section E (2017) 73, 5 774-776
a=7.1190(10)Å b=8.5190(10)Å c=13.366(2)Å
α=105.34(2)° β=90.450(10)° γ=103.38(2)°
Tetrahydroseselin
C14H16O3
Acta Crystallographica Section E (2017) 73, 8 1117-1120
a=7.2820(10)Å b=18.445(3)Å c=9.144(2)Å
α=90.00° β=96.11(3)° γ=90.00°
9-Hydroxy-2-(prop-1-en-2-yl)-2,3-dihydro-7<i>H</i>-furo[3,2-<i>g</i>]chromen-7-one
C14H12O4
Acta Crystallographica Section E (2016) 72, 4 463-466
a=7.2738(9)Å b=21.426(2)Å c=8.0152(9)Å
α=90.00° β=100.880(10)° γ=90.00°
Sesquiterpene
C15H24O2
Acta Crystallographica Section E (2016) 72, 4 460-462
a=8.849(4)Å b=5.3360(10)Å c=14.994(5)Å
α=90.00° β=99.21(2)° γ=90.00°